RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Subacute Thyroiditis After Receiving the mRNA COVID-19 Vaccine (Moderna): The First Case Report and Literature Review in Korea

      한글로보기

      https://www.riss.kr/link?id=A108017399

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Subacute thyroiditis (SAT) is a painful thyroiditis that often requires steroid therapy. Here, we report the first case of severe SAT in a patient who received the first dose of mRNA coronavirus disease 2019 (COVID-19) vaccination. A 34-year-old man without a viral prodrome felt a lump when swallowing 5 days after his first dose of mRNA-1273 (Moderna) vaccination. Ten days after vaccination, the patient visited the hospital and was advised to rest and take nonsteroidal anti-inflammatory drugs. He revisited the hospital 10 days later as symptoms aggravated with anterior neck pain, headache, fatigue, muscle weakness, and weight loss. Thyroid hormone levels and inflammatory markers were consistent with thyrotoxicosis. A thyroid ultrasound scan revealed typical SAT findings. His symptoms rapidly improved after receiving prednisone.
      A week later, the patient successfully completed his second dose of the vaccine. The thyroid function test results were nearly normal 1 month after the completion of the vaccination. We report this case to raise awareness of the occurrence of SAT after COVID-19 vaccination. As the risk of COVID-19 outweighs the minor risks of the vaccine, managing the side effects of the first vaccine dose is crucial to complete COVID-19 vaccination.
      번역하기

      Subacute thyroiditis (SAT) is a painful thyroiditis that often requires steroid therapy. Here, we report the first case of severe SAT in a patient who received the first dose of mRNA coronavirus disease 2019 (COVID-19) vaccination. A 34-year-old man w...

      Subacute thyroiditis (SAT) is a painful thyroiditis that often requires steroid therapy. Here, we report the first case of severe SAT in a patient who received the first dose of mRNA coronavirus disease 2019 (COVID-19) vaccination. A 34-year-old man without a viral prodrome felt a lump when swallowing 5 days after his first dose of mRNA-1273 (Moderna) vaccination. Ten days after vaccination, the patient visited the hospital and was advised to rest and take nonsteroidal anti-inflammatory drugs. He revisited the hospital 10 days later as symptoms aggravated with anterior neck pain, headache, fatigue, muscle weakness, and weight loss. Thyroid hormone levels and inflammatory markers were consistent with thyrotoxicosis. A thyroid ultrasound scan revealed typical SAT findings. His symptoms rapidly improved after receiving prednisone.
      A week later, the patient successfully completed his second dose of the vaccine. The thyroid function test results were nearly normal 1 month after the completion of the vaccination. We report this case to raise awareness of the occurrence of SAT after COVID-19 vaccination. As the risk of COVID-19 outweighs the minor risks of the vaccine, managing the side effects of the first vaccine dose is crucial to complete COVID-19 vaccination.

      더보기

      참고문헌 (Reference)

      1 Desailloud R, "Viruses and thyroiditis : an update" 6 (6): 5-, 2009

      2 Lee KA, "Thyrotoxicosis after COVID-19 vaccination : seven case reports and a literature review" 74 (74): 470-472, 2021

      3 Siolos A, "Thyroiditis following vaccination against COVID-19 : report of two cases and review of the literature" 12 : 100136-, 2021

      4 İremli BG, "Three cases of subacute thyroiditis following SARS-CoV-2 vaccine : postvaccination ASIA syndrome" 106 (106): 2600-2605, 2021

      5 Ruggeri RM, "Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic" 20 (20): 219-221, 2021

      6 Şahin Tekin M, "Subacute thyroiditis following COVID-19 vaccination in a 67-yearold male patient : a case report" 17 (17): 4090-4092, 2021

      7 Soltanpoor P, "Subacute thyroiditis following COVID-19 vaccination" 9 (9): e04812-, 2021

      8 Oyibo SO, "Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease(COVID-19)" 13 (13): e16045-, 2021

      9 Franquemont S, "Subacute thyroiditis after mRNA vaccine for COVID-19" 5 (5): A956-A957, 2021

      10 Saygılı ES, "Subacute thyroiditis after inactive SARS-CoV-2 vaccine" 14 (14): e244711-, 2021

      1 Desailloud R, "Viruses and thyroiditis : an update" 6 (6): 5-, 2009

      2 Lee KA, "Thyrotoxicosis after COVID-19 vaccination : seven case reports and a literature review" 74 (74): 470-472, 2021

      3 Siolos A, "Thyroiditis following vaccination against COVID-19 : report of two cases and review of the literature" 12 : 100136-, 2021

      4 İremli BG, "Three cases of subacute thyroiditis following SARS-CoV-2 vaccine : postvaccination ASIA syndrome" 106 (106): 2600-2605, 2021

      5 Ruggeri RM, "Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic" 20 (20): 219-221, 2021

      6 Şahin Tekin M, "Subacute thyroiditis following COVID-19 vaccination in a 67-yearold male patient : a case report" 17 (17): 4090-4092, 2021

      7 Soltanpoor P, "Subacute thyroiditis following COVID-19 vaccination" 9 (9): e04812-, 2021

      8 Oyibo SO, "Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease(COVID-19)" 13 (13): e16045-, 2021

      9 Franquemont S, "Subacute thyroiditis after mRNA vaccine for COVID-19" 5 (5): A956-A957, 2021

      10 Saygılı ES, "Subacute thyroiditis after inactive SARS-CoV-2 vaccine" 14 (14): e244711-, 2021

      11 Brancatella A, "Subacute thyroiditis after Sars-COV-2infection" 105 (105): dgaa276-, 2020

      12 Chatzi S, "Subacute thyroiditis after SARS-CoV-2 vaccination: a report of two sisters and summary of the literature" 1-3, 2021

      13 Patel KR, "SARS-CoV-2 vaccine-induced subacute thyroiditis" 43 (43): 103211-, 2022

      14 Chakravarthy K, "Recommendations and guidance for steroid injection therapy and COVID-19 vaccine administration from the American Society of Pain and Neuroscience (ASPN)" 14 : 623-629, 2021

      15 Das L, "Post-COVID-vaccine autoimmune/inflammatory syndrome in response to adjuvants(ASIA syndrome)manifesting as subacute thyroiditis" 1-3, 2021

      16 Schimmel J, "Letter to the editor : thyroiditis and thyrotoxicosis after the SARS-CoV-2 mRNA vaccine" 31 (31): 1440-, 2021

      17 Ohsako N, "Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing" 80 (80): 3653-3656, 1995

      18 Bornemann C, "Case report: two cases of subacute thyroiditis following SARS-CoV-2vaccination" 8 : 737142-, 2021

      19 Gowri M. Ratnayake, "Can COVID‐19 immunisation cause subacute thyroiditis?" Wiley 97 (97): 140-141, 2021

      20 Jeeyavudeen MS, "COVID-19 vaccine-associated subacute thyroiditis : an unusual suspect for de Quervain's thyroiditis" 14 (14): e246425-, 2021

      21 Watad A, "Autoimmune/inflammatory syndrome induced by adjuvants and thyroid autoimmunity" 7 : 150-, 2017

      22 Bragazzi NL, "ASIA syndrome and endocrine autoimmune disorders" 34 (34): 101412-, 2020

      23 Plaza-Enriquez L, "A case report of subacute thyroiditis following mRNA COVID-19 vaccine" 2021 : 8952048-, 2021

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 SCI 등재 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.48 0.37 1.06
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.85 0.75 0.691 0.11
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼